Tuesday, May 21, 2002 | Oncolink

Oncolink Features

Find My Cancer Drug

Cetuximab (C225) plus cisplatin/carboplatin is active in patients (pts) with recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) porgressing on a same dose and schedule platinum-based regimen Presenter: J. BaselgaPresenter's Affiliation: Institut Goustave-Roussy, Villejuif, FranceType of Session: ScientificBackground Patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)who fail first line therapy have...
Chemotherapy +/- whole-brain irradiation (WBI) for primary CNS lymphoma (PCNSL)-first experience with a randomized trial Presenter: A. KorfelPresenter's Affiliation: Klinikum Benjamin Franklin, BerlinType of Session: PosterBackground The prognosis of primary CNS lymphoma (PCNSL) is poor. The trend has been to treat without the use of whole brain radiation, as results...
Multicenter Phase III Trial to Compare Radical Nephrectomy Plus Adjuvant Autologous Tumor Cell-Lysate Vaccine Versus Radical Nephrectomy Without Adjuvant Treatment for Renal Cell Carcinoma Stages pT2-3bN0-3M0: a 3-year Analysis Presenter: C. DoehnPresenter's Affiliation: University of Luebeck Medical SchoolType of Session: ScientificBackground According to SEER data, 50% of renal cell carcinomas (RCC) are localized in extent. The five-year survival rate for localized...
p21 and p53 as prognostic factors for bladder preservation and survival in patients with bladder cancer treated with neoadjuvant chemotherapy Presenter: Garcia Del MuroPresenter's Affiliation: Institut Catala d'Oncologia-Ciutat Sanitaria de BellvitgeType of Session: ScientificBackground Muscle invasive cancer has traditionally been treated with cystectomy. However, more recently, combined...
Preliminary results fo the GORTEC 96-01 randomized trail, comparing very accelerated radiotherapy versus concomitant radio-chemotherapy for locally inoperable HNSCC Presenter: J. BourhisPresenter's Affiliation: Institute Goustave-Roussy, Villejuif, FranceType of Session: ScientificBackground Recent evidence demonstrates improved outcome in squamous cell carcinoma of the head and neck(HNSCC) with altered...
Protective Effect Of Vitamin E (VE ) In Head And Neck Cancer Radiation Induced Mucositis: A Double-Blind Randomized Trial Presenter: Paulo R FerreiraPresenter's Affiliation: Hospital de Clinicas de Porto Alegre, Porto Alegre, BrazilType of Session: ScientificBackground Vitamin E is the most important antioxidant in the human body It scavenges free radicals and prevents...
Survival and Long-Term Toxicity Results in the SCOTROC Study: Docetaxel-Carboplatin (DC) vs. Paclitaxel-Carboplatin (PC) in Epithelial Ovarian Cancer (EOC) Presenter: P.A. VaseyPresenter's Affiliation: Scottish Gynaecological Cancer Trials GroupType of Session: ScientificBackground The Scottish Gynaecological Cancer Trials Group undertook a study of DC vs. PC in FIGO stage 1C-4 EOC. Data presented at...
Updated results of a randomized controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer Presenter: R.R. HallPresenter's Affiliation: MRC Clinical Trials UnitType of Session: ScientificBackground Muscle-invasive bladder cancer continues to have a high rate of failure, with the majority with distant metastases. The use of chemotherapy,...